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Abstract 
 
We investigate the extent to which health care has contributed to the decline in mortality rates in 
Australia over recent decades by examining trends in avoidable mortality between 1968 and 
2001. Avoidable mortality refers to deaths from certain conditions that are considered to be 
largely avoidable given timely and effective health care. Using unit record mortality data, we 
classified deaths into three avoidable categories: conditions amenable to medical care (‘medical 
care indicators’ (MCI)), conditions responsive to health policy but that are considered to lack 
effective treatment once the condition has developed (‘health policy indicators’ (HPI)), and 
ischaemic heart disease (IHD). ‘Nonavoidable’ deaths included the remaining causes of death.  
 
Our findings suggest that the Australian health care system has made substantial contributions 
to the reduction in mortality over the past three decades. This is shown in the steady decline in 
avoidable mortality rates with slower declines in nonavoidable mortality rates. Between 1968 
and 2001, total avoidable death rates fell around 70% (68.4% in females, 72.2% in males) and 
nonavoidable rates fell around 34% (34.6% in females, 33.2% in males). Using Poisson 
regression, the annual declines in avoidable mortality rates were as follows (95% CIs in 
parentheses): 3.47% (3.44-3.50%) in females and 3.89% (3.86-3.91%) in males. For 
nonavoidable mortality rates, the annual declines were 1.09% (1.05-1.13%) in females and 
0.95% (0.92-0.98%) in males. The trends in avoidable mortality in Australia were similar to 
those of other European countries, with Australia improving it’s ranking between 1980 and 
1998, performing particularly well with respect to MCI. 
 
In females, declines in MCI death rates made the largest contribution to the decline in avoidable 
mortality rates (54%) with the IHD contribution being 45%. In males, reductions in IHD death 
rates made the largest contribution (57%), with the MCI contribution being 32%. For both 
sexes, most of this decline occurred in only a small number of the thirty-five MCI causes – 
cerebrovascular disease, cancer of the breast (females), cancer of the colon and rectum, 
perinatal deaths and pneumonia. Declines in HPI death rates made a negligible contribution in 
females (1%) and only a modest contribution in males (11%). 
 
While the observed declines in avoidable mortality rates may also reflect changes in other 
factors that influence mortality such as environment and socioeconomic conditions, they are 
consistent with, and suggestive of, the health care system being an important determinant of 
health improvements in Australia in recent decades. 
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INTRODUCTION 
Life expectancy in Australia, as in other developed countries, has been steadily 
increasing over the last century due to falling death rates across all ages. While the 
reduction in mortality rates in the early part of the century has been largely attributed to 
improvements in living conditions, in more recent decades health care is thought to 
have played an important role.1 The question is, to what extent has health care 
contributed to reducing mortality rates in Australia?  
 
One approach for assessing the contribution of health care to declining mortality rates is 
through the application of the concept of avoidable mortality. Avoidable mortality 
refers to deaths from certain conditions that are considered to be largely avoidable given 
timely and effective health care. Trends in avoidable mortality over time can be used to 
estimate the contribution of health care to falling mortality rates. Comparisons of these 
trends across countries or regions can indicate relative weaknesses in health care 
systems requiring further investigation.2  
 
The concept of avoidable mortality has evolved over time and has been variously 
referred to as avoidable death (e.g. Holland3), amenable mortality or death from 
amenable causes (e.g. Poikolainen & Eskola4), or mortality from diseases/conditions 
amenable to medical intervention/health care (e.g. Mackenbach et al.5). While it has 
been applied in over 70 empirical studies,2 three groups have been central to its 
development: the Preventable and Manageable Diseases Working Group chaired by 
David Rutstein,6-8 the work of John Charlton and colleagues,9-11 and the European 
Community Concerted Action Project (ECCAP) on Health Services and Avoidable 
Deaths.3 12-14  
 
In 1976, Rutstein’s group first proposed the idea of counting avoidable deaths to 
measure the quality of medical care.6 Based on expert opinion, the group identified 
causes of ‘unnecessary disease and disability’ and ‘unnecessary untimely deaths’ that 
could be used as indexes of the quality care. They listed over 70 conditions in which 
death was considered to be avoidable given timely and appropriate medical care and a 
further 23 conditions that were considered to have highly effective interventions but for 
which not all deaths would be avoidable. Medical care was defined broadly. 
Consequently, conditions included those that were medically treatable (e.g. 
  
 
2 
appendicitis), primarily preventable (e.g. lung cancer) or both (e.g. diphtheria). The 
authors suggested an immediate use of their method would be to use death record 
information to tabulate untimely deaths across the states. In 1976, Adler adopted this 
idea and published a letter reporting that 14% of deaths in the United States in 1968-
1971 were avoidable.15 
 
Charlton and colleagues were the first to publish a comprehensive study applying the 
conceptual framework developed by Rutstein’s group. They adapted the concept of 
unnecessary untimely deaths to examine the performance of the National Health Service 
across regions in England and Wales.10 From Rutstein and colleagues’ lists, they 
selected a subset of 14 diseases (plus perinatal mortality) that were regarded as most 
amenable to medical intervention and for which there was a significant number of 
deaths to allow analysis of variation across different health authorities. Age limits were 
set for each cause (mostly 5 to 64 years, with a narrower age range for selected causes) 
to increase the proportion of mortality potentially avoidable. Notably, they excluded 
from their measure deaths from conditions such as lung cancer that were dependent 
mainly on primary prevention. Applying this method, they found large variations in 
avoidable deaths across the different regions, most of which could not be explained by 
socioeconomic indicators such as the proportion of unskilled workers in the region. As 
Charlton and colleagues pointed out, regardless of whether or not disease incidence 
influenced this variation, it indicated areas that required action given that the deaths 
were potentially avoidable. Since this study, Charlton and colleagues have used various 
revisions of this list to study time trends in avoidable mortality within the U.K. and 
internationally.16-18 
 
Following Charlton and colleagues’ work, ECCAP produced a series of atlases mapping 
avoidable mortality across member countries of the European Community between 
1974 and 1989.3 12-14 These works, published between 1988 and 1997, incorporated 
several substantial revisions to the list of avoidable deaths, reflecting varying country 
participation in the project together with advances in, and definitions of, health care 
over the period. The first version of the list, based on a modification of that of Charlton 
et al., included 17 conditions.3 12 Fourteen of these conditions were considered 
avoidable given timely and appropriate medical intervention, while for three conditions 
amenability was considered to be mainly through primary prevention at the national 
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level. Like Charlton, the ECCAP Group adopted an upper age limit of 65, with a lower 
age limit for selected causes. In the second version of the list, a further eight conditions 
were included, however the extent to which health services could contribute to reducing 
mortality for these causes was described as “less certain”.13 In the final version, the 
definition of avoidable death was narrowed so that the list included 16 causes, all of 
which were considered amenable to treatment or primary or secondary prevention 
provided by health care services. Conditions where amenability was thought to be 
through prevention at a national level and more dependent on actions outside the direct 
control of the health services were excluded.14 
 
Largely based on the lists published by these three groups, there have been many 
country-specific studies of avoidable mortality. The majority of these have been set in 
Europe examining deaths in the early 70s and the late 80s. However, there have been 
many study-specific variations in the lists of avoidable deaths used. This reflects 
variation in definitions of medical or health care and what is considered avoidable 
across countries and over time. In more narrowly-defined lists, including those of 
Charlton et al.10, Mackenbach et al.19, Boys et al,20 the ECCAP group’s latest version,14 
and a recent list by Nolte and McKee,2 essentially only those causes that are amenable 
to medical intervention through primary or secondary prevention or treatment are 
included. This contrasts with other studies such as those by Albert and colleagues,21 
Tobias and Jackson,22 and Westerling and Rosen,23 that also include causes of death 
predominantly responsive to primary prevention through population level interventions 
including policies outside the direct control of health services (e.g. tobacco control and 
road safety). These studies that adopted a broader list of avoidable causes usually sub-
classify the avoidable deaths based on whether they are predominantly ‘treatable’ (also 
known as ‘medical care indicators’) or ‘preventable’ (‘health policy indicators’). Tobias 
and Jackson modified this approach, by partitioning each cause of avoidable death 
among three subcategories according to the level of intervention, i.e., primary, 
secondary and tertiary prevention, using an expert consensus process.22 
  
Time trend studies of avoidable mortality have been used to estimate the contribution of 
health care systems to reductions in mortality and to compare the effectiveness of health 
care systems across countries or regions. In nearly all of the industrialised countries 
studied, avoidable mortality rates have gradually fallen over recent decades and at a 
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faster rate than mortality from nonavoidable causes, suggesting that health care has had 
a definite impact on mortality.4 17 20 22 24-35 The few exceptions are some studies of 
Eastern European countries studied in the 1980s and 1990s.35 36  
 
Only two time trend studies have included Australia. The New South Wales (NSW) 
Department of Health investigated avoidable mortality trends in their state using the 
system developed by Tobias and Jackson, partitioning each cause of avoidable mortality 
into three levels of intervention - primary, secondary and tertiary. Consistent with 
studies of other developed countries, they found that while both avoidable and 
unavoidable death rates fell over time, avoidable death rates declined at a faster rate 
than unavoidable deaths. Between 1980 and 2000, the proportion of premature deaths 
(i.e. those occurring in those aged less than 75 years) attributable to all avoidable causes 
fell from 75% to 61%, while the proportion attributable to unavoidable causes rose from 
25% to 39%. The majority of deaths and the greatest absolute reduction in deaths during 
this time were preventable through primary level interventions, however relative 
reductions were greater for secondary and tertiary causes of death. Overall the findings 
suggest that health care interventions contributed to the reductions in mortality between 
1980 and 2000 in NSW. However, the absolute rates of avoidable mortality were 
substantially higher than those published for other countries. This is because the 
avoidable mortality classification used includes a considerably larger list of conditions 
than those in other studies, the list having been constructed to measure ‘theoretical 
scope for population gain, not what may be considered feasible given current 
technology, available resources and competing values.”22 Thus, while the historical 
trends give an indication of progress, the more comprehensive list used in the NSW 
study is less useful as a measure of the quality of contemporary care. Further, the 
relative effectiveness of the health system (i.e. compared with other countries) is not 
apparent as no comparisons were made with other regions or countries using similar 
methodology.  
 
In the other study, Kjellstrand and colleagues investigated death rates for six avoidable 
causes of death (in addition to maternal and infant mortality) for the period 1980-1990 
in order to compare the “success, cost and efficiency of modern medicine” across 10 
developed countries.34 Based on the six indicators, death rates from avoidable causes 
fell at a greater rate than “unavoidable” causes. Australia showed the greatest reduction 
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in avoidable mortality over the decade, changing its rank from fourth to second out of 
the ten countries. However, as this study used only six indicators for avoidable 
mortality, it accounted for a total of only 22 of 258 deaths per 100,000 per year (8.4%) 
in 1980 and 11 of 213 deaths per 100,000 per year (4.8%) in 1990. Moreover, the 
unavoidable group included a large number of what would normally be regarded as 
avoidable deaths.  
 
Given the limited published data on avoidable mortality in Australia, in this paper we 
examine the trends in avoidable and nonavoidable mortality in Australia between 1968 
and 2001 and compare these trends with selected European countries. This is 
particularly timely given the recently published review and update of measures of 
avoidable mortality.2 In doing this, we aim to: (1) assess the contribution of the 
Australian health care system to declining mortality rates over the past three decades, 
and (2) determine the relative effectiveness of Australia’s health care system over recent 
decades. 
 
METHODS 
We used de-identified unit record mortality data from the Australian Bureau of 
Statistics (ABS). The underlying cause of death on each unit record is based on death 
certificate information supplied by the doctor certifying that death which is then coded 
by a professional coder. The 8th Revision of the International Classification of Disease 
(ICD-8) was used for deaths registered between 1968 and 1978, ICD-9 for 1979-1998 
and ICD-10 for deaths registered from 1999 onwards. 
Largely following the work of Nolte, McKee and colleagues,2 35 we classified deaths 
into three avoidable categories: (1) conditions amenable to medical care (‘medical care 
indicators’ (MCI)), (2) conditions responsive to health policy but that are considered to 
lack effective treatment once the condition has developed (‘health policy indicators’ 
(HPI)), and (3) ischaemic heart disease (IHD). The list of conditions and their 
corresponding codes are shown in Table 1. A fourth category, ‘nonavoidable’, includes 
the remaining causes of death.  
Medical care indicators, which Nolte and McKee refer to as amenable mortality, are 
conditions that are considered to have identifiable effective interventions that are 
administered by health care providers. They include conditions “from which it is 
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expected death to be averted even after the condition has developed”.2 This definition 
necessarily excludes preventable conditions that have a relative lack of effective 
treatment once they have developed (e.g. lung cancer, liver cirrhosis). We used Nolte 
and McKee’s recently updated list that was developed after an extensive review of the 
literature and which is largely based on the work of Charlton,10 Mackenbach,37 and 
Tobias and Jackson.38 It takes account of recent advances in health care and extends the 
age limit to 74 years for most conditions to reflect increasing life expectancy. A detailed 
justification for the selection of these conditions and the age limit set (at 74 for most 
causes) is outlined in Nolte and McKee’s review.2 Our list of MCI differs to that of 
Nolte and McKee only in that we have included asthma. This was not included in their 
final list because of the inability to separately access the code for this condition from 
the World Health Organization mortality files from which they sourced their data. There 
are also some minor coding differences that are noted in Table 1.  
The three HPI causes on our list are those consistently used in studies that include such 
causes in the definition of avoidable mortality.13 19 21 23 26 35 36 39 40 The ICD-8 and ICD-9 
codes for these causes are taken from the second ECCAP list.13 To derive the ICD-10 
codes for these causes, we used mapping tables supplied by the National Centre for 
Classification in Health in Australia. 
Ischaemic heart disease is classified separately, in line with the argument that this 
condition lies somewhere between the ‘health policy’ and ‘medical care’ categories. 
Moreover, the extent to which medical care contributes to reductions in mortality from 
this condition remains uncertain and primary prevention is understood to contribute 
significantly. Further, if IHD were enumerated in the MCI category, the large number of 
deaths from this cause is likely to obscure the contribution of other causes in this 
group.2 35 
Using direct standardisation, we calculated age-standardised annual mortality rates in 
males and females aged less than 75 years for the four categories of death (MCI, HPI, 
IHD and nonavoidable causes). To estimate person-years at risk, we used population 
data supplied by the ABS. These data are estimates of the Australian mid-year resident 
population by 5-year age bands and sex (population data for 1968-1970 are 
arithmetically interpolated from census data which are based on actual place of 
enumeration not usual residence41). We used the Australian 2001 population for rate 
standardisation.
  
 
7 
Table 1 Avoidable causes of death 
 
Cause of Death Age 
Range 
ICD-8 ICD-9 ICD-10 
 
 
Medical Care Indicators 
Intestinal infections 0-14 000-009 001-009 A00-A09 
Tuberculosis 0-74 010-019 010-018, 137 A15-A19, B90 
Other infections (diphtheria, 
tetanus, poliomyelitis 
0-74 032, 037, 040-
043 
032, 037, 045 A36, A35, A80 
Whooping cough  0-14 033 033 A37 
Septicaemia 0-74 038 038 A40-A41 
Measles  1-14 055 055 B05 
Malignant neoplasm of colon 
and rectum 
0-74 153-154 153-154 C18-C21 
Malignant neoplasm of skin 
(excl. melanoma) 
0-74 173 173 C44 
Malignant neoplasm of breast 0-74 174 174 C50 
Malignant neoplasm of cervix 
uteri 
0-74 180 180 C53 
Malignant neoplasm of cervix 
uteri and body of uterus (excl. 
overlap with above codes) 
0-44 182 179, 182 C54-C55 
Malignant neoplasm of testis 0-74 186 186 C62 
Hodgkin’s disease 0-74 201 201 C81 
Leukaemia 0-44 204-207 204-208 C91-C95 
Disease of the thyroid 0-74 240-246 240-246 E00-E07 
Diabetes mellitus 0-49 250 250 E10-E14 
Epilepsy 0-74 345 345 G40-G41 
Chronic rheumatic heart 
disease 
0-74 393-398 393-398 I05-I09 
Hypertensive disease 0-74 400-404 401-405 I10-I13, I15 
Cerebrovascular disease 0-74 430-438 430-438 I60-I69 
G45 
All respiratory diseases 
(excl. pneumonia/influenza) 
1-14 460-466 
490-519 
460-479 
488-519 
J00-J06 
J20-J99 
Influenza 0-74 470-474 487 J10-J11 
Pneumonia 0-74 480-486 480-486 J12-J18 
Peptic ulcer 0-74 531-533 531-533 K25-K27 
Appendicitis 0-74 540-543 540-543 K35-K38 
Abdominal hernia 0-74 550-553 550-553 K40-K46 
Cholelithiasis and 
cholecystitis 
0-74 574-575 574-575.1 K80-K81 
Nephritis and Nephrosis 0-74 580-584 580-589 N00-N07, N17-
N19, N25-N27 
Benign prostatic hyperplasia 0-74 600 600 N40 
Maternal deaths All 630-678 630-676 O00-O99 
Congenital cardiovascular 
abnormalities 
0-74 746-747 745-747 Q20-Q28 
Perinatal deaths (excl. 
stillbirths) 
All 760-779 760-779 P00-P96, A33-
A34 
Misadventures to patients 
during surgical and medical 
care (incl. complications) 
All E930-E936 E870-876, 
E878-E879 
Y60-Y69, 
Y83-Y84 
Asthma 0-74 493 493 J45-J46 
 
(continued…) 
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Table 1 Avoidable causes of death (continued) 
Cause of Death Age 
Range 
ICD-8 ICD-9 ICD-10 
 
 
Ischaemic heart disease 
 
0-74 
 
 
410-414 
 
 
410-414 
 
 
I20-I25 
 
 
Health Policy Indicators 
Malignant neoplasm of 
trachea, bronchus & lung 
0-74 162 162 C33-C34 
Chronic liver disease and 
cirrhosis  
0-74 571 571 K70, K71.7, 
K73-K74, K76.0 
Motor vehicle accident 0-74 E810-E823 E810-E825 V02-V04, 
V06.1, V09.0-
V09.3, 
V12-V14, 
V19.0-v19.6 
V20-v79 
V80.3-V80.5, 
V81.0-V81.1, 
V82.0-V82.1, 
V83.0-V83.3, 
V84-V88, 
V89.0, 
V89.2-V89.9 
 
Notes. 
1. Causes and codes for medical care indicators taken from Nolte and McKee2 with the 
following exceptions: (a) “Chronic rheumatic heart disease” ICD-8 codes listed in source as 
393-396, corrected to 393-398; (b) code G45 (transient ischemic attack) added to ICD-10 
cerebrovascular disease codes (transient ischaemic attack already included in ICD-8 and ICD-9 
codes);  (c) “All respiratory diseases (excl. influenza/pneumonia)” listed in source as  J00-J09, 
J20-J99 corrected to  J00-J06, J20-J99; (d) ICD-9 code 771.3 (tetanus neonatorum) added to 
perinatal death category (tetanus neonatorum already included in ICD-10 category, and in ICD-
8 is included in “Other infections” as part of tetanus (A037)); (e) ICD-8 codes for 
“Misadventures to patients during medical or surgical care” supplied by the authors; (f) 
“Asthma” added to list. 
2. Codes for health policy indicators taken from Holland for ICD-8 and ICD-9,13 and assigned 
by author for ICD-10 as indicated in Methods. 
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Rates were calculated by actual year of death for 1968 (the year ICD-8 coding was first 
used in Australia) to 2001, based on deaths registered between 1968 and 2002. Given 
that a proportion of deaths is registered after the actual year of death, not all deaths 
occurring in these years will necessarily be counted. However, analysis of deaths in 
Australia has shown that less than 0.1% of deaths are registered after the second year.42  
 
In addition to presenting the directly age-standardised rates, we modelled mortality 
trends using Poisson regression. The observed number of deaths by year and age group 
were assumed to be Poisson distributed, fitting a log-linear rate equation with log of 
person-years as an offset. Annual rates of change in mortality rates were calculated by 
exponentiation of the coefficient for trend (annual percent change = [exp (coef) – 1] x 
100). 
 
RESULTS 
Overall trends in avoidable and nonavoidable mortality in Australia 
Age-standardised mortality rates for the three avoidable death categories (MCI, HPI, 
IHD) and for nonavoidable deaths from 1968 to 2001 are shown in Figure 1 (see also 
table in Appendix). The steady decline in total mortality rates over this period was 
largely due to the fall in deaths from avoidable rather than nonavoidable causes, in both 
females and males. Taking all avoidable causes together, the death rates in females fell 
from 323 to 102 deaths per 100,000 person years (68.4%), and rates in males fell from 
600 to 167 per 100,000 person years (72.2%). Using Poisson regression, the annual 
decline in death rates was 3.47% (95% confidence interval 3.44-3.50%) in females and 
3.89% (95% CI 3.86-3.91%) in males.  
 
Over the same period, the fall in death rates from nonavoidable causes was less 
pronounced. Female nonavoidable death rates fell from 159 to 104 deaths per 100,000 
person years (34.6%) and male rates declined from 274 to 183 deaths per 100,000 
person years (33.2%). Using Poisson regression, the annual decline in rates was 1.09% 
(95% CI 1.05-1.13) in females and 0.95% (95% CI 0.92-0.98%) in males. Thus, 
between 1968 and 2001, the proportion of total mortality attributed to avoidable causes 
fell in both males and females. Avoidable causes declined from approximately two 
thirds of total deaths (67.0% and 68.6%, females and males respectively) to one half of 
all deaths (49.6% and 47.7%, females and males, respectively).  
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Figure 1. Age-standardised death rates (in population aged 0-74 years) for the three 
avoidable death categories - medical care indicators, ischaemic heart disease and health 
policy indicators - and nonavoidable deaths, 1968-2001. 
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To examine the patterns of avoidable and nonavoidable mortality across age groups, we 
stratified our sample into groups: 0-4 years, then by ten-year intervals. Results are 
shown in Figures 2 and 3. Between 1968 and 2001 total avoidable mortality rates 
declined in all age groups, with annual percentage declines lowest in those aged 25-34 
years (2.75% with 95% CI 2.55-2.94% in females and 2.93% with 95% CI 2.80-3.07% 
in males). Declines were highest in those aged 0-4 years (5.36% with 95% CI 5.23-
5.48% in females and 5.61% with 95% CI 5.50-5.71% in males). Nonavoidable rates 
also declined in most age groups, but more slowly than for avoidable mortality. Annual 
percentage declines in females ranged between 0.42% (95% CI 0.37-0.48%), in those 
aged 65-74 years, and 2.72% (95% CI 2.58-2.87%), in those aged 0-4 years. In males 
the rates ranged between 0.17% (95% CI 0.07-0.27%), in those aged 35-44 years, and 
2.94% (95% CI 2.70-3.19%), in those aged 5-14 years. There were two exceptions to 
the nonavoidable mortality pattern. First, in females aged 15-24 years there was no 
significant fall in nonavoidable death rates (annual decline of 0.13%, 95% CI -0.08-
0.35%). Second, in males aged 15-24 and 25-34 years increasing rates of nonavoidable 
deaths were observed (annual increases of 0.34% (95% CI 0.21-0.46%) and 1.45% 
(95% CI 1.33-1.56%), respectively).a 
 
Trends in mortality rates for medical care indicators 
Medical care indicator death rates fell from 177 to 58 deaths per 100,000 person years 
in females (67.2%), and from 190 to 52 deaths per 100,000 person years in males 
(72.6%), between 1968 and 2001. Poisson regression showed an annual death rate 
decline of 3.42% (95% CI 3.38-3.46%) for MCI deaths in females and 4.00% (95% CI 
3.96-4.04%) in males. Although death rates for MCI were lower in females than males, 
the proportion of total avoidable mortality attributed to MCI was higher in females 
(range 51-57%, between 1968 and 2001) than males (26-32%). Over half of the decline 
in avoidable mortality rates in females (54%), and a third (32%) in males, was 
attributable to MCI. (See table in Appendix). 
                                                 
a These patterns can be partly explained by an overall rise in suicide rates, particularly in young 
men. Between 1968-1970 and 1999-2001, rates rose from 11.7 to 21.3 suicide deaths per 
100,000 person years, and 20.9 to 34.2 suicide deaths per 100,000 person years, in 15-24 year 
old and 25-34 year old males, respectively. In females aged 15-24 years, rates rose from 4.6 to 
5.5 suicide deaths per 100,000 person years. With suicide excluded, the nonavoidable death rate 
actually falls over time in females and males aged 15-24 years.  
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Figure 2. Avoidable and nonavoidable death rates by age group – females (0-74 years) 
Note. Because of the large variation in death rates across age groups, different scales are used. 
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Figure 3. Avoidable and nonavoidable death rates by age group – males (0-74 years) 
Note. Because of the large variation in death rates across age groups, different scales are used. 
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There was a significant decline in death rates for all except four of the 35 causes in the 
female population and five of the causes in the male population. For two of these MCI 
causes - septicaemia and misadventures to patients during surgical and medical care - 
deaths rates actually increased over time, while death rates from two others - whooping 
cough and malignant neoplasm of the skin - showed no significant change, in both 
female and males. These four causes contributed little to the avoidable mortality rates - 
all had death rates of less than 3 per 100,000 in any particular year. In addition, death 
rates for cancer of the colon and rectum in males (around 17 per 100,000 person years 
at the start and the end of the 34 year period) showed an increasing trend before starting 
to fall in the late 80s.  
 
To determine the MCI causes that contributed most to avoidable mortality, we 
calculated 3-year average mortality rates for the start of the period (1968-1970) and for 
the end of the period (1999-2001). As shown in Table 2, the five MCI causes with the 
highest death rates in both periods in males and females were cerebrovascular disease, 
malignant neoplasm of the colon and rectum, perinatal deaths and pneumonia, and, in 
females only, malignant neoplasm of the breast. Together, these leading causes 
contributed over 70% of the total MCI death rate in females in 1968-1970 (72%) and 
1998-2000 (78%), and around 70% in males (69% and 73% for the two periods, 
respectively). Rates for all other MCI were 10 per 100,000 person years or less, with 
most causes having rates of less than 2 per 100,000 person years, in both periods. 
Cerebrovascular disease, perinatal deaths and pneumonia showed the greatest absolute 
declines in mortality rates of the MCI between 1968-1970 and 1998-2000. 
 
The fall in MCI death rates between 1968 and 2001 was evident across all age groups. 
However, two contrasting age-specific trends are of note. First, the proportion of 
avoidable deaths that could be attributed to MCI was particularly high in those aged 0-4 
years over the entire period (an average of 94% (range: 91-96%) in females and 94% 
(91-97%) in males). Second, this proportion was notably smaller in those aged 15-24 
years than in the other age groups (30% (range: 22-40%) and 14% (9-22%), females 
and males, respectively). 
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Table 2. Leading Medical Care Indicator (MCI) death rates (per 100,000 person 
years) in population aged 0-74 years 
 Females Males 
 1968-1970 1999-2001 1968-1970 1999-2001 
     
Cerebrovascular disease  67.51 11.43 75.76 15.35 
Malignant neoplasm of 
breast 
 22.47 18.99 - - 
Malignant neoplasm of 
colon and rectum 
 16.81 11.18 17.90 17.20 
Perinatal deaths  12.02   3.01  17.67  4.09 
Pneumonia   9.41   1.66*  17.13  2.55 
All other MCI  50.22 13.17  58.77 14.70 
TOTAL MCI 178.43 59.44 187.23 53.89 
* Because of the large fall in pneumonia deaths, this cause fell from 5th to 6th largest with 
cervical cancer (both categories combined) having higher rates than pneumonia in 1999-2001 
with 2.08 deaths per 100,000 person years. 
 
Trends in mortality rates for ischaemic heart disease 
There was a large fall in IHD death rates between 1968 and 2001, from 122 to 22 deaths 
per 100,000 person years in females (82.0%), and from 310 to 63 deaths per 100,000 
person years in males (79.7%). The annual decline was 4.76% (95% CI 4.71-4.81%) 
and 4.62% (95% CI 4.59-4.66%) in females and males, respectively. Just under half of 
the decline in avoidable mortality rates in females (45%), and over half (57%) in males, 
was attributable to IHD. (See table in Appendix). The large IHD death rates in males 
account for a large portion of the sex difference in total mortality. The IHD trends are 
largely accounted for by those aged 35 years and older, with IHD death rates in younger 
age groups being very low and hence changing little over time. 
 
Trends in mortality rates for health policy indicators 
Overall, HPI contributed relatively little to the decline in mortality between 1968 and 
2001 and showed a different pattern to the other categories of death. Reductions in HPI 
death rates accounted for less than 1% of the decline in avoidable mortality in females 
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and 11% in males. While the proportion of avoidable mortality attributed to HPI was 
relatively small, this proportion rose steadily over the 34-year period from around 7% to 
21% in females and 17% to 31% in males (see table in Appendix).   
 
In females, there was actually an increase in HPI over time, with 24 per 100,000 person 
years in 1968, peaking at 30 deaths per 100,000 person years in 1978. There was no 
appreciable decline occurring until the 1990s, with the rate falling to 22 per 100,000 
person years by 2001 (an overall decline of 8.3%). However, this pattern of aggregate 
causes of deaths masks the true picture as the three HPI causes in females show 
different trends over this period. As shown in Figure 4, there was a considerable rise in 
tobacco-related deaths (malignant neoplasm of the trachea, bronchus and lung) with an 
annual increase of 2.36% (95% CI 2.24-2.49%), mostly accounted for by deaths in 
those aged 65-74 years. In contrast, there was a significant fall in motor vehicle deaths 
of 3.55% per year (95% CI 3.42-3.67%); and after initially rising, a small overall fall in 
deaths from chronic liver disease and cirrhosis of 2.01% per year (95% CI 1.80-2.23%). 
  
In males, the pattern of HPI deaths was different to that of females. The overall HPI rate 
fell from 100 deaths to 51 deaths per 100,000 persons (49%), representing an average 
annual decline of 2.34% (95% CI 2.30-2.39%), with most of the decline occurring after 
1983. Overall, annual death rates declined for all three causes. Motor vehicle accidents 
declined 4.11% (95% CI 4.03-4.18%), malignant neoplasm of the trachea, bronchus and 
lung declined 1.31% (95% CI 1.25-1.37%), and chronic liver disease and cirrhosis 
declined 1.70% (95% CI 1.57-1.83%). However, death rates from the latter two causes 
actually rose during the 1970s before falling thereafter (see Figure 4). 
 
The overall patterns for HPI across age groups generally followed similar trends to 
those described above. However, HPI made a relatively larger contribution to the 
avoidable mortality rate in both sexes in younger age groups (those aged 5-14, 15 to 24 
and 25-34 years), due to the large proportion of deaths from motor vehicle accidents. 
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Figure 4. Deaths rates (per 100,000 person years) for HPI causes (population 0-74 years) 
Note. Because of the large differences in death rates across sex, different scales are used. 
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Comparisons between Australian and European avoidable mortality trends 
We compared avoidable mortality trends in Australia with those in Europe using results 
recently published by Nolte and McKee for selected European countries for the years 
1980, 1990 and 1998.2 In order to do this, we needed to make several adjustments to our 
method: We (1) excluded asthma, (2) classified only MCI and IHD (and not HPI) as 
avoidable mortality, and (3) directly age-standardised rates using the European standard 
population. 
 
The age-standardised avoidable mortality rates for the nine European countries for 
which there are comparable data,b and for Australia, are shown in Figures 5 and 6. 
Comparisons across countries show similar patterns in both females and males. There 
were substantial declines in MCI death rates in all countries between 1980 and 1990 and 
between 1990 and 1998, the declines being steepest in the 1980s (Figure 5). With few 
exceptions, the rankings of countries for MCI death rates changed little across the three 
time periods (see Table 3). In 1980, Australian females had the fourth lowest MCI rate 
with 110 deaths per 100,000 person years. This compares with a median rate across 
countries of 119 deaths per 100,000 person years, with France having the lowest rate 
with 86 deaths per 100,000 person years, and Portugal the highest with 181 deaths per 
100,000 person years. In 1998, Australian females were ranked third lowest with 64 
deaths per 100,000 person years (median: 70.37), compared with France with 61 deaths 
per 100,000 person years, and Portugal with 97 deaths per 100,000 person years. In 
terms of MCI deaths as percentage of total deaths, Australia’s ranking was similar 
across the time periods, being fourth in 1980 with 32.3% (median: 34.0%, range: 28.5-
43.7%), and second in 1998 with 28.3% (median:  29.4%, range:  28.2-35.0%).  
 
Similar rankings were evident in Australian males. In 1980, they had the third lowest 
MCI rate when compared with European males, being 117 per 100,000 person years. 
This compares with a median rate across countries of 132 deaths per 100,000 person 
years, again with France having the lowest rate with 88, and Portugal the highest with 
251, deaths per 100,000 person years. By 1998, Australia was ranked the lowest, with 
60 deaths per 100,000 person years (median: 72.0), compared with France with 65,
                                                 
b Nolte and McKee examined 12 European countries. However, for three of these (Denmark, 
Finland, and Sweden) selected amenable causes were excluded in the calculation of rates so the 
rates for these countries are not directly comparable with those for Australia. 
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Figure 5. Deaths rates (per 100,000 person years) for medical care indicators in Australia 
and selected European countries (population aged 0-74 years) 
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Table 3. Avoidable mortality rates (per 100,000 person years) and ranks in 
Australia and selected European countries (population aged 0-74 years) 
  MCI  MCI & IHD 
 1980 1998 1980 1998 
 Rate Rank Rate Rank Rate Rank Rate Rank 
FEMALES         
AUSTRALIA 110.06   4  64.01  3 185.74   8  92.23   4 
AUSTRIA 128.54   8  69.41  5 175.91   7 102.06   7 
FRANCE   86.31   1  60.62  1 105.63   1  70.27   1 
GERMANY* 118.44   5  74.39  7 165.34   6 104.69   8 
GREECE 127.08   7  71.32  6 151.98   4  94.78   5 
ITALY 119.68   6  67.91  4 152.52   5  85.01   3 
NETHERLANDS   96.31   2  75.00  8 144.53   3 101.52   6 
PORTUGAL 181.39 10  96.86 10 211.35   9 115.84   9 
SPAIN 105.75   3  61.93  2 126.70   2  76.74   2 
U.K. 146.90   9  89.28  9 229.27 10 134.51 10 
Median 119.06   70.37  158.93   98.15  
         
MALES         
AUSTRALIA 116.52   3  60.00   1 333.96   8 141.07   4 
AUSTRIA 164.05   9  76.39   8 314.17   7 182.09   8 
FRANCE 107.10   2  64.87   2 178.72   1 105.57   1 
GERMANY* 135.01   6  76.37   7 299.54   6 170.37   7 
GREECE 127.90   4  73.39   6 215.20   3 155.53   6 
ITALY 143.10   7  70.00   4 250.70   4 131.02   3 
NETHERLANDS   87.92   1  67.31   3 255.01   5  145.64   5 
PORTUGAL 251.39 10 130.42 10 335.25   9 189.11   9 
SPAIN 128.79   5  70.54   5 202.59   2 128.53   2 
U.K. 146.16   8  85.58   9 396.88 10 211.78 10 
Median 131.90  71.97  277.28  150.59  
* As data for west Germany were only available to 1990 from the World Health Organization mortality 
files, additional data were obtained from the Statistical Office Germany. Because separate data for east 
and west Berlin are no longer available after 1997 from this source, 1997 data are used in this analysis 
instead of 1998 data. 
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and Portugal 130, deaths per 100,000 person years. In terms of MCI deaths as a 
percentage of total deaths, Australia ranked third in both 1980, with 17.0%, (median: 
20.2%, range: 14.0-30.5%), and 1998, with 14.5% (median: 15.0%, range: 12.9-21.3%). 
 
Including both MCI and IHD as avoidable deaths results in similar patterns of decline in 
avoidable death rates across countries, but the absolute declines were obviously larger 
than when MCI deaths alone are included (see Figure 6). Notably, including IHD as an 
avoidable cause worsens Australia’s rankings for both females and males due to the 
relatively high IHD death rates in this country (see Table 3). France and the United 
Kingdom were ranked first and last, respectively, in both 1980 and 1998, in both sexes. 
In Australian females, avoidable death rates that include IHD are third highest (ranked 
eighth) in 1980, with 186 deaths per 100,000 person years (54.5% of total deaths). The 
median rate across all countries is 159 deaths per 100,000 person years (range: 106-229) 
and the median as a percentage of total deaths is 45.7% (range: 34.9-56.1%). However, 
by 1998, Australia had improved its ranking considerably to fourth with 92 deaths per 
100,000 person years (median (range) across all countries: 98 (70-135)). Nevertheless, 
as a percentage of total deaths, Australia maintained a lower ranking at sixth (40.8%, 
median (range): 40.5% (32.6-45.0%)). However, it is worth noting that between 1980 
and 1998, Australian females showed the greatest decline in IHD rates in both absolute 
and percentage terms compared with females in the other countries. 
 
Similarly, for Australian males in 1980 the avoidable death rate including IHD is third 
highest (ranked eighth) with 334 deaths per 100,000 person years (48.6% of total 
deaths). The median for all countries is 277 deaths per 100,000 person years (39.9% of 
total deaths), with France having 179 deaths per 100,000 person years (25.6%) and the 
United Kingdom 397 deaths per 100,000 person years (53.4%).  
 
However, by 1998, Australia had improved its ranking considerably to fourth lowest 
(141 deaths per 100,000 person years; median (range): 151 (106-212)). When 
measuring avoidable deaths as a percentage of total deaths, however, Australia’s 
ranking remained low (ninth with 34.1%; median: 32.0% (21.0-43.0%)). However, like 
the female population, Australian males showed the greatest decline in IHD rates 
between 1980 and 1998 of any of these countries, in both absolute and percentage 
terms. 
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Figure 6. Deaths rates (per 100,000 person years) for medical care indicators and ischemic 
heart disease (combined) in Australia and selected European countries (population aged 0-
74 years) 
Note. Different to the scale used in Figure 5. 
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DISCUSSION 
The avoidable mortality approach offers a simple method for estimating the impact of 
health care systems on mortality. Using this approach, our findings suggest that the 
Australian health care system has made substantial contributions to the reduction in 
mortality over the past three decades. This is shown in the steady decline in avoidable 
mortality rates. Moreover, the rate of decline has been faster than that for nonavoidable 
deaths, with deaths from avoidable causes falling from approximately two-thirds to half 
of total deaths over a 34-year period. These patterns of avoidable mortality are 
consistent with those in studies set in Europe, Asia and North America that have used 
similar measures of avoidable and nonavoidable deaths.4 17 20 22 24-35  
 
Limitations 
When interpreting the avoidable mortality patterns, several points about the 
classification are worth noting. As originally discussed by Rutstein and his colleagues, 
the chain of events that leads to death may be long and complex, thus the partitioning of 
deaths into those that are avoidable, and those that are not, is an inexact science.6 
Indeed, not all deaths categorised as avoidable are necessarily avoidable, rather a 
substantial proportion could be avoided through appropriate and timely health care. 
Further, the list of avoidable causes is not intended to cover all causes possibly treatable 
and/or preventable and the nonavoidable category will contain a proportion, albeit 
relatively small, of avoidable deaths. Finally, many conditions amenable to medical care 
are also preventable so the MCI reflect the impact of health policy to some degree, and 
similarly, the HPI partly reflect medical care. This is particularly important to bear in 
mind when interpreting the rates for HPI - health policy may have made a greater 
contribution to mortality than the findings suggest given that MCI include a subset of 
conditions that are also responsive to health policy. To a lesser extent, HPI will also 
reflect medical care advances, particularly in the management of motor vehicle trauma. 
 
Critics of avoidable mortality have argued that the concept is limited because it does not 
take into account underlying disease incidence, i.e. lower death rates over time or across 
regions may just reflect lower incidence rates. This also needs to be kept in mind when 
interpreting the avoidable mortality rates given that varying incidence may reflect 
genetic, social and environmental influences, not just health care. However, this 
limitation is partly countered by Charlton and colleagues who point out that regardless 
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of whether or not disease incidence influences variation in death rates, high avoidable 
mortality rates indicate areas of potential health system weakness given that the deaths 
are potentially avoidable.10 Further, avoidable mortality studies that have taken into 
account underlying disease incidence as measured by routinely collected morbidity data 
have found that this only partly accounts for the observed variation in avoidable 
mortality. 18 43Moreover, adjusting for incidence rates may lead to an underestimation 
(and where incidence rates actually increase, an overestimation) of the effectiveness of 
health care given such rates will, themselves, be at least partly determined by health 
care. 
 
Finally, there were changes in coding practices during the series, with three successive 
versions of the ICD being implemented, and a change from a manual to automated 
cause of death coding in 1997.44 While this potentially raises problems of time trends 
reflecting these changes, the use of aggregate categories means that any coding changes 
are unlikely to affect the results substantially. In our series, there were no changes in 
trends, in either direction or magnitude, in the three avoidable death categories or the 
nonavoidable category when new ICD editions were introduced, nor when the coding 
practice changed from a manual to an automated coding system. Such changes in 
coding practices, particularly the latter, are more relevant when looking at trends in 
individual causes of death. The single cause of avoidable death most affected by the 
changes is pneumonia. Under manual coding (prior to 1997), and when ICD-10 coding 
was introduced (after 1998), pneumonia deaths were often coded as a chronic 
underlying condition such as Alzheimer’s disease or malignant neoplasm This means an 
underestimation of pneumonia deaths compared with 1997 and 1998.42 44 Nevertheless, 
pneumonia deaths, at least when not associated with a chronic underlying condition, 
have fallen substantially over this period. 
 
Explanation of trends 
The decline in avoidable mortality in Australia has mostly been due to falling rates of 
IHD, these being particularly dramatic in men. These well-documented declines reflect 
health policy interventions through reductions in smoking and dietary risk factors, and 
through medical care including prevention (management of abnormal blood pressure 
and cholesterol levels) and acute and subacute coronary care (e.g. surgical interventions 
such as bypass grafts and angioplasties).45-49  
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The absolute decline in MCI death rates has also been substantial. The causes that 
contributed most to this decline were cerebrovascular disease, perinatal deaths and 
pneumonia, these causes having high death rates at the start of the period. For 
cerebrovascular disease, health care interventions that are likely to have contributed to 
the decline in mortality include primary intervention such as carotid endarterectomy50 
and the management of modifiable risk factors using drug therapies for hypertension 
and hypercholesterolemia,51 secondary prevention, e.g. using anticoagulant therapy for 
preventing stroke recurrence,52 and tertiary intervention such as the use of organised 
stroke units.53 54 Interpreting the impact of the health system on perinatal mortality is 
complex due to several interacting factors. The rates must be seen in the context of 
decreasing fertility rates in Australia1 which alone will result in lower perinatal 
mortality rates over time as the rates in this study are given as a proportion of the total 
population not as a proportion of live births. Nevertheless, a range of health care 
interventions such as the introduction of neonatal intensive care units and improved 
paediatric and obstetric care have contributed substantially to the decline in perinatal 
mortality.55 56 Further, improved prenatal screening for congenital abnormalities leading 
to termination will have influenced the perinatal death rate although this is difficult to 
quantify given notification of terminations is incomplete in Australia.57 The downward 
trend in deaths from pneumonia in Australia has been previously well documented, 
much of the mortality decline from this condition and that of other infectious diseases in 
the last half century attributable to the health care system, including mass application of 
antibiotics and immunisation.58 
 
The trends in avoidable mortality in Australia for MCI and IHD are similar to those of 
other European countries, although there is variation in the absolute rates. For 
comparisons based on MCI alone, Australia performs well and has actually improved its 
ranking over the past two decades. However, with IHD included, Australia’s rankings 
fall due to its relatively higher rates of IHD deaths. This fall in Australia’s ranking with 
the inclusion of IHD has been previously documented.59 However, taking a snapshot of 
these rates obscures the fact that Australia has shown the greatest improvement in IHD 
rates since 1980, suggesting that our health system is actually performing relatively 
better than static rankings alone suggest. 
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Deaths rates in Australia for HPI have declined at a slower rate overall than for IHD and 
MCI. This reflects the increasing rather than decreasing rates of malignant neoplasm of 
the trachea, bronchus and lung over the entire period in women and up until the early 
80s in men. Importantly, the lag between the exposure and onset of disease means that 
the effectiveness of any tobacco control interventions are not fully realised in these 
trends. The falling rate of lung cancer in men reflects the dramatic decline in the 
smoking rate in this population over the past several decades, while prevalence rates in 
women, although lower overall, have fallen at a slower rate, having started to fall only 
in the early 1980s.60 61 In contrast to lung cancer, falling death rates from motor vehicle 
accidents have been a major contributor to the decline in avoidable mortality over the 
34-year period in women, men and children. While much of this decline can be 
attributed to transport safety initiatives including national laws regarding alcohol 
control, speeding, and the wearing of seatbelts and child restraints, medical care has 
also made major contributions to the declining mortality rate.62 
 
The relatively shallow decline in nonavoidable deaths was expected given that the 
overall decline in mortality over this period was anticipated to be mainly due to those 
causes responsive to healthcare intervention. The decline that did occur may represent 
the impact of factors outside of health care such as improvements in living standards. 
However, it may also reflect contributions of the health care sector given that the 
nonavoidable category is expected to contain a small proportion of avoidable deaths. 
  
Conclusion 
Over the period 1968 to 2001, Australia experienced a 68% decline in avoidable 
mortality rates for women and a 72% decline for men. The corresponding declines in 
non-avoidable mortality were 35% and 33%. Given that avoidable deaths were around 
two-thirds of all deaths for both sexes at the start of this period, these declines in 
avoidable mortality rates are substantial and have translated into marked improvements 
in life expectancy over this period. 
 
For women, a little over one-half (54%) of the decline in avoidable mortality rates was 
attributable to a decline in the MCI death rate, while another 45% was accounted for by 
declines in IHD death rates. For men, reductions in IHD death rates accounted for the 
largest decline in the avoidable mortality rate (57%) while reductions in the MCI death 
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rate accounted for 32%. Reductions in HPI death rates accounted or a negligible 
proportion of the decline in avoidable mortality rates in women (1%) but made a more 
pronounced contribution for men (11%). 
 
In international comparisons with nine European counties for which comparable data 
are available for the years 1980, 1990 and 1998, MCI and IHD avoidable mortality rates 
in Australia are within the range for these countries with respect to the absolute level of, 
and the decline in, avoidable mortality. Within this range, Australia’s ranking improved 
from eighth to fourth over the period for both sexes for combined MCI and IHD 
avoidable mortality rates. 
 
The analyses presented in this paper suggest that the health system in Australia has 
played an important role in improving the health of the nation. Defining avoidable 
deaths as those amenable to intervention through the health care system, it has been 
shown that avoidable mortality rates have declined substantially over this period. It has 
also been shown that, over the last two decades, Australia’s ranking with respect to such 
rates has improved in comparison with nine European countries. While the observed 
declines in avoidable mortality rates may also reflect changes in other factors that 
influence mortality such as environment and socioeconomic conditions, they are 
consistent with, and suggestive of, the health care system being an important 
determinant of health improvements in Australia in recent decades. 
 
  
 
28 
REFERENCES 
1. Australian Bureau of Statistics. Year Book Australia. Canberra: Australian Bureau of 
Statistics, 2004. 
2. Nolte E, McKee M. Does health care save lives? Avoidable mortality revisited. 
London: The Nuffiled Trust, 2004. 
3. Holland WW, editor. European Community Atlas of 'Avoidable Death'. European 
Communities Health Services Research Series No. 3. Oxford: Oxford University 
Press, 1988. 
4. Poikolainen K, Eskola J. The effect of health services on mortality: decline in death 
rates from amenable and non-amenable causes in Finland, 1969-81. Lancet 
1986;1(8474):199-202. 
5. Mackenbach JP, Kunst AE, Looman CW, Habbema JD, van der Maas PJ. Regional 
differences in mortality from conditions amenable to medical intervention in The 
Netherlands: a comparison of four time periods. J Epidemiol Community Health 
1988;42(4):325-32. 
6. Rutstein DD, Berenberg W, Chalmers TC, Child CG, 3rd, Fishman AP, Perrin EB. 
Measuring the quality of medical care. A clinical method. N Engl J Med 
1976;294(11):582-8. 
7. Rutstein DD, Berenberg W, Chalmers TC, Child CG, 3rd, Fishman AP, Perrin EB. 
"Measuring the quality of medical care": revision of tables of indexes. N Engl J 
Med 1977;297(9):508. 
8. Rutstein DD, Berenberg W, Chalmers TC, Fishman AP, Perrin EB, Zuidema GD. 
Measuring the quality of medical care: second revision of tables of indexes. N 
Engl J Med 1980;302(20):1146. 
9. Charlton JR, Bauer R, Thakhore A, Silver R, Aristidou M. Unemployment and 
mortality: a small area analysis. J Epidemiol Community Health 1987;41(2):107-
13. 
10. Charlton JR, Hartley RM, Silver R, Holland WW. Geographical variation in 
mortality from conditions amenable to medical intervention in England and 
Wales. Lancet 1983;1(8326 Pt 1):691-6. 
11. Charlton JR, Holland WW, Lakhani A, Paul EA. Variations in avoidable mortality 
and variations in health care. Lancet 1987;1(8537):858. 
12. Holland WW, editor. European Community Atlas of 'Avoidable Death'. Vol I. 
Commission of the European Communities Health Services Research Series No. 
6. Second ed. Oxford: Oxford University Press, 1991. 
13. Holland WW, editor. European Community Atlas of 'Avoidable Death'.  Vol II. 
Commission of the European Communities Health Services Research Series No. 
9. Second ed. Oxford: Oxford University Press, 1993. 
14. Holland WW, editor. European Community Atlas of 'Avoidable Death' 1985-1989. 
Oxford: Oxford University Press, 1997. 
15. Adler GS. Measuring the quality of medical care. N Engl J Med 1978;298(10):574. 
16. Charlton J, Lakhani A, Aristidou M. How have 'avoidable death' indices for England 
and Wales changed? 1974-78 compared with 1979-83. Community Med 
1986;8(4):304-14. 
  
 
29 
17. Charlton JR, Velez R. Some international comparisons of mortality amenable to 
medical intervention. Br Med J (Clin Res Ed) 1986;292(6516):295-301. 
18. Bauer RL, Charlton JR. Area variation in mortality from diseases amenable to 
medical intervention: the contribution of differences in morbidity. Int J Epidemiol 
1986;15(3):408-12. 
19. Mackenbach JP, Looman CW, Kunst AE, Habbema JD, van der Maas PJ. Post-1950 
mortality trends and medical care: gains in life expectancy due to declines in 
mortality from conditions amenable to medical intervention in The Netherlands. 
Soc Sci Med 1988;27(9):889-94. 
20. Boys RJ, Forster DP, Jozan P. Mortality from causes amenable and non-amenable to 
medical care: the experience of eastern Europe. BMJ 1991;303(6807):879-83. 
21. Albert X, Bayo A, Alfonso JL, Cortina P, Corella D. The effectiveness of health 
systems in influencing avoidable mortality: a study in Valencia, Spain, 1975-90. 
J Epidemiol Community Health 1996;50(3):320-5. 
22. Tobias M, Jackson G. Avoidable mortality in New Zealand, 1981-97. Aust N Z J 
Public Health 2001;25(1):12-20. 
23. Westerling R, Rosen M. 'Avoidable' mortality among immigrants in Sweden. Eur J 
Public Health 2002;12(4):279-86. 
24. Simonato L, Ballard T, Bellini P, Winkelmann R. Avoidable mortality in Europe 
1955-1994: a plea for prevention. J Epidemiol Community Health 
1998;52(10):624-30. 
25. Gil LM, Rathwell T. The effect of health services on mortality: amenable and non-
amenable causes in Spain. Int J Epidemiol 1989;18(3):652-7. 
26. Niti M, Ng TP. Temporal trends and ethnic variations in amenable mortality in 
Singapore 1965-1994: the impact of health care in transition. Int J Epidemiol 
2001;30(5):966-73. 
27. Mackenbach JP, Looman CW, Kunst AE, Habbema JD, van der Maas PJ. Regional 
differences in decline of mortality from selected conditions: The Netherlands, 
1969-1984. Int J Epidemiol 1988;17(4):821-9. 
28. Malcolm MS, Salmond CE. Trends in amenable mortality in New Zealand 1968-
1987. Int J Epidemiol 1993;22(3):468-74. 
29. Gaizauskiene A, Gurevicius R. Avoidable mortality in Lithuania. J Epidemiol 
Community Health 1995;49(3):281-4. 
30. Hisnanick JJ, Coddington DA. Measuring human betterment through avoidable 
mortality: a case for universal health care in the USA. Health Policy 
1995;34(1):9-19. 
31. Humblet PC, Lagasse R, Leveque A. Trends in Belgian premature avoidable deaths 
over a 20 year period. J Epidemiol Community Health 2000;54(9):687-91. 
32. Lakhani A, Charlton J, Aristidou M. Mortality from causes amenable to health 
services intervention. The Lancet 1986:1029. 
33. Marshall SW, Kawachi I, Pearce N, Borman B. Social class differences in mortality 
from diseases amenable to medical intervention in New Zealand. Int J Epidemiol 
1993;22(2):255-61. 
  
 
30 
34. Kjellstrand CM, Kovithavongs C, Szabo E. On the success, cost and efficiency of 
modern medicine: an international comparison. J Intern Med 1998;243(1):3-14. 
35. Nolte E, Scholz R, Shkolnikov V, McKee M. The contribution of medical care to 
changing life expectancy in Germany and Poland. Soc Sci Med 
2002;55(11):1905-21. 
36. Logminiene Z, Nolte E, McKee M, Valius L, Gaizauskiene A. Avoidable mortality 
in Lithuania: 1991-1999 compared with 1970-1990. Public Health 
2004;118(3):201-10. 
37. Mackenbach J. How important have medical advances been? In: Sussex J, editor. 
Improving population health in industrialised countries. London: Office of 
Health Economics, 2000:53-69. 
38. Tobias MI, Cheung J. Monitoring health inequalities: life expectancy and small area 
deprivation in New Zealand. Popul Health Metr 2003;1(1):2. 
39. Malcolm M. Avoidable mortality and life expectancy in New Zealand. J Epidemiol 
Community Health, 1994:211. 
40. Andreev EM, Nolte E, Shkolnikov VM, Varavikova E, McKee M. The evolving 
pattern of avoidable mortality in Russia. Int J Epidemiol 2003;32(3):437-46. 
41. Australian Bureau of Statistics. Australian Historical Population Statistics. Cat no. 
3105.0.65.001. Canberra: Australian Bureau of Statistics, 2003. 
42. Australian Bureau of Statistics. Causes of Death Australia, 2002. Cat no.: 3303.0. 
Canberra: Australian Bureau of Statistics, 2003. 
43. Treurniet HF, Looman CW, van der Maas PJ, Mackenbach JP. Variations in 
'avoidable' mortality: a reflection of variations in incidence? Int J Epidemiol 
1999;28(2):225-32. 
44. Australian Bureau of Statistics. Causes of Death Australia, 1999. Cat no.: 3303.0. 
Canberra: Australian Bureau of Statistics, 2000. 
45. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. 
Estimation of contribution of changes in classic risk factors to trends in coronary-
event rates across the WHO MONICA Project populations. Lancet 
2000;355(9205):675-87. 
46. Capewell S, Beaglehole R, Seddon M, McMurray J. Explanation for the decline in 
coronary heart disease mortality rates in Auckland, New Zealand, between 1982 
and 1993. Circulation 2000;102(13):1511-6. 
47. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. An 
analysis of the comparative effects of medical interventions and changes in 
lifestyle. Ann Intern Med 1984;101(6):825-36. 
48. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams 
LW, et al. The recent decline in mortality from coronary heart disease, 1980-
1990. The effect of secular trends in risk factors and treatment. JAMA 
1997;277(7):535-42. 
49. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, et 
al. Estimation of contribution of changes in coronary care to improving survival, 
event rates, and coronary heart disease mortality across the WHO MONICA 
Project populations. Lancet 2000;355(9205):688-700. 
  
 
31 
50. [No author]. Beneficial effect of carotid endarterectomy in symptomatic patients 
with high-grade carotid stenosis. North American Symptomatic Carotid 
Endarterectomy Trial Collaborators. N Engl J Med 1991;325(7):445-53. 
51. Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-Cordoliani MA, Lucas C, 
Bordet R. Stroke prevention: management of modifiable vascular risk factors. J 
Neurol 2002;249(5):507-17. 
52. Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with 
nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic 
attack (Cochrane Review). The Cochrane Library. Chichetser, UK: John Wiley & 
Sons, Ltd, 2004. 
53. Cadilhac DA, Ibrahim J, Pearce DC, Ogden KJ, McNeill J, Davis SM, et al. 
Multicenter comparison of processes of care between Stroke Units and 
conventional care wards in Australia. Stroke 2004;35(5):1035-40. 
54. Collaboration SUT. Organised inpatient (stroke unit) care for stroke (Cochrane 
review). The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd, 2004. 
55. Chan A, Robertson EF, Haan EA, Keane RJ, Ranieri E, Carney A. Prevalence of 
neural tube defects in South Australia, 1966-91: effectiveness and impact of 
prenatal diagnosis. BMJ 1993;307(6906):703-6. 
56. Stanley FJ, Waddell VP. Changing patterns of perinatal and infant mortality in 
Western Australia: implications for prevention. Med J Aust 1985;143(9):379-81. 
57. Hurst T, Shafir E, Day P, Lancaster P. Congenital Malformations Australia 1995-
1996. Birth Defects Series No. 3 AIHW Cat. No. PER-8. Canberra: AIHW, 1999. 
58. Bi P, Whitby M, Walker S, Parton KA. Trends in mortality rates for infectious and 
parasitic diseases in Australia: 1907-1997. Intern Med J 2003;33(4):152-62. 
59. Nolte E, McKee M. Measuring the health of nations: analysis of mortality amenable 
to health care. BMJ 2003;327(7424):1129. 
60. White V, Hill D, Siahpush M, Bobevski I. How has the prevalence of cigarette 
smoking changed among Australian adults? Trends in smoking prevalence 
between 1980 and 2001. Tob Control 2003;12 Suppl 2:ii67-74. 
61. Program VSaH. Tobacco in Australia: Facts and Issues. Melbourne: Victorian 
Smoking and Health Program, Australia (Quit Victoria), 1995. 
62. Atkinson L, Merry G. Advances in neurotrauma in Australia 1970-2000. World J 
Surg 2001;25(9):1224-9. 
 
  
 
32
 
 
 
 
Appendix Table 
Age-standardised annual death rates (per 100,000 person years in population aged 0-74 years) by sex, 
for medical care indicators (MCI), ischaemic heart disease (IHD), health policy indicators (HPI), 
total avoidable (MCI, IHD and HPI combined), total nonavoidable (total minus total avoidable) and total deaths. 
 
Year MCI IHD HPI Total avoidable Total nonavoidable Total 
 Rate % Rate % Rate % Rate % Rate % Rate 
FEMALES           
1968 177.32 54.96 121.56 37.68 23.73 7.36 322.61 67.04 158.57 32.96 481.18 
1969 172.98 54.21 120.75 37.84 25.39 7.96 319.12 67.80 151.58 32.20 470.70 
1970 184.75 54.54 125.46 37.04 28.55 8.43 338.76 68.29 157.27 31.71 496.03 
1971 163.97 53.98 113.90 37.49 25.92 8.53 303.78 67.26 147.87 32.74 451.65 
1972 159.78 54.32 109.44 37.21 24.93 8.48 294.16 66.77 146.38 33.23 440.53 
1973 150.69 53.42 104.93 37.20 26.46 9.38 282.08 66.41 142.69 33.59 424.77 
1974 152.81 53.34 107.18 37.42 26.47 9.24 286.46 66.44 144.71 33.56 431.17 
1975 142.59 53.08 99.83 37.16 26.19 9.75 268.61 66.49 135.35 33.51 403.96 
1976 139.96 53.26 95.23 36.24 27.59 10.50 262.78 66.48 132.48 33.52 395.26 
1977 129.10 52.02 90.69 36.54 28.37 11.43 248.15 65.78 129.10 34.22 377.26 
1978 121.34 50.70 88.11 36.81 29.89 12.49 239.34 64.67 130.77 35.33 370.11 
1979 113.81 50.98 81.02 36.29 28.41 12.73 223.24 64.32 123.85 35.68 347.09 
1980 111.46 52.05 75.85 35.41 26.86 12.54 214.17 63.57 122.75 36.43 336.92 
1981 107.17 50.80 76.32 36.17 27.49 13.03 210.98 63.65 120.51 36.35 331.50 
1982 107.34 51.27 73.74 35.22 28.30 13.51 209.38 62.86 123.71 37.14 333.09 
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Appendix Table: Age-standardised annual death rates (continued) 
 
Year MCI IHD HPI Total avoidable Total nonavoidable Total 
 Rate % Rate % Rate % Rate % Rate % Rate 
1983 101.77 50.61 71.98 35.80 27.32 13.59 201.07 62.16 122.43 37.84 323.50 
1984 101.46 51.46 68.61 34.80 27.10 13.74 197.16 61.57 123.05 38.43 320.21 
1985 101.68 52.17 65.66 33.69 27.54 14.13 194.88 60.94 124.90 39.06 319.77 
1986 94.99 51.08 63.62 34.21 27.38 14.72 185.99 61.01 118.88 38.99 304.87 
1987 92.67 51.57 60.47 33.65 26.56 14.78 179.70 60.01 119.76 39.99 299.46 
1988 89.48 51.58 56.41 32.52 27.59 15.90 173.47 59.40 118.55 40.60 292.02 
1989 90.06 52.08 54.85 31.71 28.03 16.21 172.94 58.63 122.05 41.37 294.99 
1990 83.78 52.19 51.02 31.78 25.73 16.03 160.52 57.91 116.69 42.09 277.21 
1991 81.91 53.43 45.73 29.83 25.65 16.73 153.28 57.17 114.83 42.83 268.11 
1992 78.67 53.39 44.88 30.46 23.80 16.15 147.35 55.64 117.46 44.36 264.81 
1993 76.55 54.10 40.99 28.97 23.96 16.93 141.49 56.08 110.83 43.92 252.32 
1994 76.63 55.02 37.64 27.02 25.01 17.96 139.28 55.15 113.27 44.85 252.55 
1995 73.35 54.94 35.55 26.63 24.61 18.43 133.51 54.57 111.14 45.43 244.65 
1996 71.59 55.78 32.87 25.62 23.87 18.60 128.33 53.74 110.48 46.26 238.81 
1997 69.24 55.64 31.38 25.22 23.81 19.13 124.43 52.62 112.06 47.38 236.48 
1998 65.57 55.94 28.72 24.50 22.91 19.55 117.20 52.03 108.06 47.97 225.26 
1999 60.68 55.77 25.63 23.56 22.49 20.67 108.80 49.88 109.33 50.12 218.14 
2000 59.73 55.50 25.04 23.26 22.86 21.24 107.63 50.38 105.99 49.62 213.61 
2001 57.76 56.62 22.40 21.96 21.85 21.42 102.02 49.59 103.68 50.41 205.70 
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Appendix Table: Age-standardised annual death rates (continued) 
 
Year MCI IHD HPI Total avoidable Total nonavoidable Total 
 Rate % Rate % Rate % Rate % Rate % Rate 
MALES           
1968 189.63 31.64 309.72 51.67 100.04 16.69 599.38 68.60 274.38 31.40 873.76 
1969 181.70 31.21 298.95 51.36 101.46 17.43 582.11 68.23 270.99 31.77 853.10 
1970 189.80 31.79 304.17 50.95 103.04 17.26 597.01 68.08 279.88 31.92 876.89 
1971 166.01 30.40 279.93 51.26 100.16 18.34 546.10 67.85 258.81 32.15 804.91 
1972 164.58 30.48 277.82 51.44 97.63 18.08 540.03 67.36 261.69 32.64 801.72 
1973 159.75 30.08 269.72 50.79 101.61 19.13 531.08 67.24 258.71 32.76 789.79 
1974 160.78 30.31 266.65 50.27 102.97 19.41 530.39 66.67 265.19 33.33 795.59 
1975 143.37 28.52 255.15 50.75 104.20 20.73 502.72 67.04 247.15 32.96 749.87 
1976 139.88 28.41 249.44 50.67 103.00 20.92 492.31 66.28 250.44 33.72 742.76 
1977 128.95 27.60 237.66 50.87 100.56 21.53 467.18 66.03 240.31 33.97 707.49 
1978 124.38 27.56 226.36 50.15 100.62 22.29 451.35 65.27 240.16 34.73 691.51 
1979 117.49 27.11 216.50 49.96 99.35 22.93 433.34 64.78 235.61 35.22 668.95 
1980 113.76 27.22 205.90 49.27 98.28 23.52 417.94 63.77 237.43 36.23 655.37 
1981 107.40 26.29 202.06 49.47 99.00 24.24 408.46 63.63 233.42 36.37 641.88 
1982 106.37 26.85 193.62 48.87 96.22 24.29 396.21 62.32 239.57 37.68 635.78 
1983 97.27 26.37 183.33 49.70 88.26 23.93 368.87 61.89 227.13 38.11 596.00 
1984 96.91 26.79 177.72 49.13 87.09 24.08 361.72 61.42 227.22 38.58 588.94 
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Appendix Table: Age-standardised annual death rates (continued) 
Year MCI IHD HPI Total avoidable Total nonavoidable Total 
 Rate % Rate % Rate %  Rate % Rate % 
1985 94.51 27.13 166.84 47.90 86.99 24.97 348.34 60.09 231.31 39.91 579.65 
1986 87.84 26.73 157.51 47.93 83.24 25.33 328.60 59.45 224.16 40.55 552.76 
1987 85.92 26.71 153.71 47.79 82.01 25.50 321.63 58.40 229.10 41.60 550.72 
1988 82.55 26.87 143.80 46.81 80.84 26.32 307.18 57.35 228.48 42.65 535.67 
1989 84.32 27.74 139.63 45.93 80.05 26.33 303.99 56.74 231.81 43.26 535.80 
1990 76.60 28.06 125.87 46.11 70.50 25.83 272.97 54.73 225.75 45.27 498.72 
1991 72.30 27.95 117.23 45.33 69.09 26.71 258.62 54.32 217.50 45.68 476.12 
1992 71.77 28.39 113.58 44.92 67.49 26.69 252.84 53.26 221.89 46.74 474.73 
1993 68.84 28.89 105.46 44.26 63.96 26.85 238.26 52.80 212.99 47.20 451.25 
1994 70.19 30.03 99.46 42.55 64.09 27.42 233.74 51.58 219.39 48.42 453.12 
1995 65.89 29.61 94.81 42.60 61.85 27.79 222.55 51.25 211.69 48.75 434.24 
1996 65.02 30.12 89.68 41.54 61.17 28.34 215.88 50.66 210.24 49.34 426.11 
1997 62.92 30.99 83.62 41.18 56.52 27.83 203.05 49.53 206.89 50.47 409.95 
1998 59.05 30.58 77.34 40.05 56.72 29.37 193.12 48.57 204.51 51.43 397.63 
1999 54.33 30.11 72.90 40.39 53.24 29.50 180.47 47.18 202.03 52.82 382.51 
2000 54.79 31.91 65.63 38.22 51.29 29.87 171.70 47.00 193.62 53.00 365.32 
2001 52.39 31.42 63.22 37.92 51.10 30.65 166.71 47.65 183.13 52.35 349.84 
Note. Denominator for percentages for MCI, IHD and HPI is total avoidable death rate; denominator for percentages for total avoidable and nonavoidable is total 
death rate. 
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